Clinical and epidemiological analysis of bone marrow transplantation in a pediatric oncology unit;Análise clínica e epidemiológica do transplante de medula óssea em um serviço de oncologia pediátrica

Jornal de Pediatria

Volumn 79, Issue 5, 2003, Pages 413-422

  De Castro Jr , Cláudio Galvão ^a   Gregianin, Lauro José ^b   Brunetto, Algemir Lunardi ^b  

^a Servico de Oncol Pediatrica   (Brazil)

^b NONE

Author keywords

Bone marrow transplantation; Hematopoietic stem cell; Pediatric cancer; Umbilical cord blood

Indexed keywords

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD; BONE MARROW; BONE MARROW TRANSPLANTATION; BRAZIL; BURKITT LYMPHOMA; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CELL COUNT; CHEDIAK HIGASHI SYNDROME; CHILD; CHILDHOOD CANCER; CHRONIC GRAFT REJECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; DIARRHEA; FANCONI ANEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HOSPITAL DEPARTMENT; HUMAN; INFECTION; MALE; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; NEPHROBLASTOMA; NEUROECTODERM TUMOR; NEUTROPHIL; NONHODGKIN LYMPHOMA; RHABDOMYOSARCOMA; SEPSIS; THROMBOCYTE; UMBILICAL CORD BLOOD; VOMITING;

EID: 0242460528     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-75572003000500008     Document Type: Article

References (25)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-38.
2. Castro CG Jr, Gregianin LJ, Brunetto AL. Transplante de medula óssea e transplante de sangue de cordão umbilical em pediatria. J Pedíatr (Rio J) 2001;77:345-60.
3. Ferreira E, Dulley FL, Morsoletto F, Neto JZ, Pasquini R. Bone marrow transplantation in Brazil. Hum Immunol 1985;14:324-32.
4. Pallota Filho RS. Transplante de medula óssea em crianças e adolescentes com idade menor ou igual a 18 anos. Análise de 96 transplantes [dissertação]. Faculdade de Medicina. Universidade de São Paulo; 2001, 103 p,
5. Bonfim C, Pasquini R. Comunicação pessoal. Serviço de Transplante de Medula Óssea-Hospital das Clínicas de Curitiba; 2002.
6. Seber A, Ginani VC, Gonçalves AV, Morais MFC, Oliveira OMW, Amorim JE, et al. Transplante de medula óssea: experiência do Instituto de Oncologia Pediátrica. Anais do VIII Congresso da Sociedade Brasileira de Oncologia Pediátrica; 2002. Poster 178, 75.
7. Azevedo WM. Comunicação pessoal. Hospital das Clínicas. Universidade Federal de Minas Gerais; 2002.
8. Mauad MA. Comunicação pessoal. Hospital Amaral Carvalho de Jaú - SP; 2002.
9. Common Toxicity Criteria - Version 2.0. National Institute of Health. [site na Internet]. Disponível: http://ctep.info.nih.gov. Acessado: 18 de setembro de 2002.
10. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
11. a ed. Filadélfia: Lippincott & Wilkins; 2000. p. 641-648.
12. a ed. Filadélfia: Lippincott & Wilkins; 2000. p. 575-593.
13. Saboya R. Infecções bacterianas e fúngicas no transplante de medula óssea - análise de 186 pacientes [tese]. Faculdade de Medicina - Universidade de São Paulo; 1998. 254 p.
14. Benjamin DK Jr, Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002;21:227-34.
15. Perters C, Minkov M, Gadner H, Klingebiel T, Vossen J, Locatelli F, et al. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 2000;26:405-11.
16. Sanders JE. Bone marrow transplantation for pediatric malignancies. Pediatr Clin North Am 1997;4:1005-20.
17. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002;100:415-19.
18. Vigorito AC, Azevedo WM, Marques JF, Azevedo AM, Eid KA, Aranha FJ, et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998;22:1145-51.
19. Bittencourt H, Rocha V, Chevret S, Socié G, Esperou H, Devergie A, et al. Association of CD-34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002;99:2726-33.
20. 6 CD 34 + cells for autologous stem cell transplantation significantly reduces febrile complications and the use of antibiotics after transplantation. Bone Marrow Transplant 1999;23:1177-81.
21. Horowitz MM, Keating A. IBMTR/ABMTR Newsletter 2000; 7:3-10.
22. Pein F, Michon J, Valteau-Couanet D, Quintana E, Frappaz D, Vannier JP, et al. High-dose melphalan, etoposide and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology Study. J Clin Oncol 1998;16:3295-3301.
23. Hawkins D, Barnett T, Bensinger W, Gooley T, Sanders J. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors. Med Pediatr Oncol 2000;34: 328-37.
24. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73.
25. Verdeguer A, Pardo N, Madero L, Martinez A, Bureo E, Fernandez JM, et al. Autologous stem cell transplantation for advanced Hodgkin's disease in children. Spanish group for BMT in children (GETMON), Spain. Bone Marrow Transplant 2000;25:31-4.